Synovics Pharmaceuticals Inc. Stock Analysis SYVC

Synovics Pharmaceuticals, Inc. engages in the manufacture and sale of pharmaceutical and dietary supplement products. The company is headquartered in Fort Lauderdale, Florida and currently employs 155 full-time employees. The firm is a manufacturer, packager and distributor of private label, or store brand, OTC products to chain drug stores, wholesalers and distributors throughout the United States. The Company’s OTC product categories include analgesics, cough and cold, antihistamines, asthma relief and laxatives. The firm has two primary subsidiaries, Kirk Pharmaceuticals, LLC (Kirk), and ANDAPharm, LLC (ANDAPharm). Kirk manufactures and distributes OTC products developed by or licensed to the Company. ANDAPharm serves as the product research and RX manufacturing arm of the Company with a focus on the development of active compounds for drugs.